Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1990 Dec;27(12):738–741. doi: 10.1136/jmg.27.12.738

A 90 kb DNA deletion associated with neurofibromatosis type 1.

M Upadhyaya 1, A Cheryson 1, W Broadhead 1, A Fryer 1, D J Shaw 1, S Huson 1, M R Wallace 1, L B Andersen 1, D A Marchuk 1, D Viskochil 1, et al.
PMCID: PMC1017276  PMID: 2127432

Abstract

A deletion of 90 kb of DNA has been identified in a patient with neurofibromatosis type 1, using pulsed field gel electrophoresis. The deletion lies between probes 17L1A and AC5 in the critical region of chromosome 17 and represents the only molecular alteration found by PFGE in a series of 90 unrelated patients. The subject showing the deletion is an isolated case, shows typical clinical features, and represents one of the first examples of a molecular deletion to be found in this disorder.

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker D., Wright E., Nguyen K., Cannon L., Fain P., Goldgar D., Bishop D. T., Carey J., Baty B., Kivlin J. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science. 1987 May 29;236(4805):1100–1102. doi: 10.1126/science.3107130. [DOI] [PubMed] [Google Scholar]
  2. Cawthon R. M., O'Connell P., Buchberg A. M., Viskochil D., Weiss R. B., Culver M., Stevens J., Jenkins N. A., Copeland N. G., White R. Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. Genomics. 1990 Aug;7(4):555–565. doi: 10.1016/0888-7543(90)90199-5. [DOI] [PubMed] [Google Scholar]
  3. Collins F. S., O'Connell P., Ponder B. A., Seizinger B. R. Progress towards identifying the neurofibromatosis (NF1) gene. Trends Genet. 1989 Jul;5(7):217–221. doi: 10.1016/0168-9525(89)90085-1. [DOI] [PubMed] [Google Scholar]
  4. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  5. Fountain J. W., Wallace M. R., Bruce M. A., Seizinger B. R., Menon A. G., Gusella J. F., Michels V. V., Schmidt M. A., Dewald G. W., Collins F. S. Physical mapping of a translocation breakpoint in neurofibromatosis. Science. 1989 Jun 2;244(4908):1085–1087. doi: 10.1126/science.2543076. [DOI] [PubMed] [Google Scholar]
  6. Huson S. M., Compston D. A., Clark P., Harper P. S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 1989 Nov;26(11):704–711. doi: 10.1136/jmg.26.11.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kunkel L. M., Smith K. D., Boyer S. H., Borgaonkar D. S., Wachtel S. S., Miller O. J., Breg W. R., Jones H. W., Jr, Rary J. M. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1245–1249. doi: 10.1073/pnas.74.3.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ledbetter D. H., Rich D. C., O'Connell P., Leppert M., Carey J. C. Precise localization of NF1 to 17q11.2 by balanced translocation. Am J Hum Genet. 1989 Jan;44(1):20–24. [PMC free article] [PubMed] [Google Scholar]
  9. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988 May;45(5):575–578. [PubMed] [Google Scholar]
  10. O'Connell P., Leach R., Cawthon R. M., Culver M., Stevens J., Viskochil D., Fournier R. E., Rich D. C., Ledbetter D. H., White R. Two NF1 translocations map within a 600-kilobase segment of 17q11.2. Science. 1989 Jun 2;244(4908):1087–1088. doi: 10.1126/science.2543077. [DOI] [PubMed] [Google Scholar]
  11. O'Connell P., Viskochil D., Buchberg A. M., Fountain J., Cawthon R. M., Culver M., Stevens J., Rich D. C., Ledbetter D. H., Wallace M. The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations. Genomics. 1990 Aug;7(4):547–554. doi: 10.1016/0888-7543(90)90198-4. [DOI] [PubMed] [Google Scholar]
  12. Seizinger B. R., Rouleau G. A., Ozelius L. J., Lane A. H., Faryniarz A. G., Chao M. V., Huson S., Korf B. R., Parry D. M., Pericak-Vance M. A. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell. 1987 Jun 5;49(5):589–594. doi: 10.1016/0092-8674(87)90534-4. [DOI] [PubMed] [Google Scholar]
  13. Upadhyaya M., Sarfarazi M., Huson S. M., Broadhead W., Fryer A., Harper P. S. Close flanking markers for neurofibromatosis type I (NF1). Am J Hum Genet. 1989 Jan;44(1):41–47. [PMC free article] [PubMed] [Google Scholar]
  14. Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver M., Carey J. C., Copeland N. G., Jenkins N. A. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990 Jul 13;62(1):187–192. doi: 10.1016/0092-8674(90)90252-a. [DOI] [PubMed] [Google Scholar]
  15. Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M., Fountain J. W., Brereton A., Nicholson J., Mitchell A. L. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990 Jul 13;249(4965):181–186. doi: 10.1126/science.2134734. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES